Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicinsensitive transplantable rhabdomyosarcoma
Aim: To evaluate the efficacy of different variants of immunotherapy, namely, adoptive LAK-therapy, vaccine therapy and their combination in vivo using transplantable murine MC-rhabdomyosarcoma resistant and sensitive to doxorubicin (Dox). Materials and Methods: The study was carried out on BALB/c m...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2007 |
| Main Authors: | Belova, O.B., Vinnichuk, U.D., Shlakhovenko, V.A., Berezhnaya, N.M. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2007
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/139015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicinsensitive transplantable rhabdomyosarcoma / O.B. Belova, U.D. Vinnichuk, V.A. Shlakhovenko, N.M. Berezhnaya // Experimental Oncology. — 2007. — Т. 29, № 4. — С. 272–276. — Бібліогр.: 37 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
-
The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and В16 melanoma resistant to doxorubicin
by: Berezhnaya, N.M., et al.
Published: (2008) -
Antitumor action of lymphokin-activated сеlls of patients with soft tissue sarcomas and melanomas in dependence on expression of MHC classes I and II antigenes
by: Berezhnaya, N.M., et al.
Published: (2006) -
Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action
by: Berezhnaya, N.M., et al.
Published: (2009) -
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008) -
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)